Development of endogenous glucocorticoids, mineralocorticoids and progestins in the human fetal and perinatal period. Influence of antenatal treatment with betamethasone or phenobarbital.
D000653:Amniotic Fluid / Q000378:metabolism; D001623:Betamethasone / Q000494:pharmacology*; D005260:Female; D005333:Fetus / Q000378:metabolism*; D005865:Gestational Age; D005938:Glucocorticoids / Q000096:biosynthesis*; D006801:Humans; D007231:Infant, Newborn; D008901:Mineralocorticoids / Q000096:biosynthesis*; D010634:Phenobarbital / Q000494:pharmacology*; D011247:Pregnancy; D011372:Progestins / Q000096:biosynthesis*; D013256:Steroids / Q000097:blood
D005938:Glucocorticoids; D008901:Mineralocorticoids; D011372:Progestins; D013256:Steroids; D001623:Betamethasone; D010634:Phenobarbital